Randomized, double-blind, placebo-controlled, consumer rechallenge test of Olean salted snacks

被引:14
作者
Zorich, NL
Biedermann, D
Riccardi, KA
Bishop, LJ
Filloon, TG
机构
[1] Department of Medical Affairs, OLEAN, Procter and Gamble Company, Cincinnati
关键词
D O I
10.1006/rtph.1997.1164
中图分类号
DF [法律]; D9 [法律]; R [医药、卫生];
学科分类号
0301 ; 10 ;
摘要
Olestra is a zero-calorie fat substitute that is neither digested nor absorbed. A randomized, double-blind, placebo-controlled, within-subject, crossover rechallenge study was conducted to compare the occurrence of gastrointestinal symptoms after ingestion of chips made with Olean brand of olestra or conventional triglycerides in subjects who had previously experienced gastrointestinal symptoms they attributed to consuming Olean. A total of 57 male or female subjects received 2 oz of Olean potato chips or triglyceride potato chips at each of four weekly site visits. The occurrence of gastrointestinal effects after product consumption was noted in follow-up telephone interviews 3 to 5 days after each visit. There was no significant difference in the frequency of any gastrointestinal symptoms (abdominal cramping, diarrhea, loose stools) following consumption of Olean chips or triglyceride chips, and the severity of diarrhea, loose stools, and abdominal cramping was similar. We conclude that consumption of a 2-oz serving of Olean chips is no more likely to result in reports of gastrointestinal symptoms than consumption of triglyceride snacks as a part of the usual diet, even in individuals who have claimed intolerance to Olean. The data suggest that subjects who previously experienced symptoms that they attributed to consuming products made with Olean may have mistakenly attributed their symptoms to these products. (C) 1997 Academic Press.
引用
收藏
页码:200 / 209
页数:10
相关论文
共 26 条
[1]   OLESTRA, A NONDIGESTIBLE, NONABSORBABLE FAT - EFFECTS ON GASTROINTESTINAL AND COLONIC TRANSIT [J].
AGGARWAL, AM ;
CAMILLERI, M ;
PHILLIPS, SF ;
SCHLAGHECK, TG ;
BROWN, ML ;
THOMFORDE, GM .
DIGESTIVE DISEASES AND SCIENCES, 1993, 38 (06) :1009-1014
[2]  
*AM MED ASS COUNC, 1985, JAMA-J AM MED ASSOC, V254, P400
[3]   LACTOSE AND MILK INTOLERANCE - CLINICAL IMPLICATIONS [J].
BAYLESS, TM ;
ROTHFELD, B ;
MASSA, C ;
WISE, L ;
PAIGE, D ;
BEDINE, MS .
NEW ENGLAND JOURNAL OF MEDICINE, 1975, 292 (22) :1156-1159
[4]  
BERGHOLZ CM, 1992, ACS SYM SER, V484, P391
[5]   POSTMARKETING SURVEILLANCE OF FOOD-ADDITIVES [J].
BUTCHKO, HH ;
TSCHANZ, C ;
KOTSONIS, FN .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 1994, 20 (01) :105-118
[6]  
CHESKIN L, IN PRESS J AM MED AS
[7]   EFFECTS OF SUCROSE POLYESTER ON CHOLESTEROL-METABOLISM IN MAN [J].
CROUSE, JR ;
GRUNDY, SM .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1979, 28 (10) :994-1000
[8]  
EASTWOOD MA, 1995, EUR J CLIN NUTR, V49, P627
[9]   SHORT-TERM STUDY OF SUCROSE POLYESTER A NONABSORBABLE FAT-LIKE MATERIAL AS A DIETARY AGENT FOR LOWERING PLASMA CHOLESTEROL [J].
FALLAT, RW ;
GLUECK, CJ ;
LUTMER, R ;
MATTSON, FH .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1976, 29 (11) :1204-1215
[10]   EFFECT OF SUCROSE POLYESTER ON FECAL BILE-ACID EXCRETION AND COMPOSITION IN NORMAL MEN [J].
GLUECK, CJ ;
JANDACEK, RJ ;
SUBBIAH, MTR ;
GALLON, L ;
YUNKER, R ;
ALLEN, C ;
HOGG, E ;
LASKARZEWSKI, PM .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1980, 33 (10) :2177-2181